Eppendorf AG introduced the TF Chip Stem Cell kit. Eppendorf AG and the Joint Research Center of the EU validated the firm’s DualChip GMO microarray kit. BioDiscovery released NEXUS CGH 2 software. Tecan AG introduced the QuadChamber for fully automated processing of four different microarrays simultaneously on one slide, which is validated for use with […]
Arthur Holden, Illumina Senior Vice President of Corporate and Market Development, resigned from the company in fall 2007. Rosetta Biosoftware’s Syllego System achieved Affymetrix GeneChip-compatibility status. Eppendorf Biochip Systems GmbH certified Girus Life Sciences as a service provider. Oxford Gene Technology granted a license to Phalanx Biotech to fabricate and sell arrays in the US. […]
On January 15, the Korean Science and Technology Ministry released a plan to place Korea among the top three countries for nanotechnology by 2020. According to the plan, by 2020, Korean companies would control 20% of the global nanotechnology market, generating sales of $260 billion per year by 2015 and $500 billion in 2020. Nano-element […]
Affymetrix received a four-year, $10.2 million grant from the National Human Genome Research Institute for the ENCODE (ENCylopedia Of DNA Elements) project. Laboratory Corporation of America will use Affymetrix’s whole genome microarrays for a new molecular cytogenetic service for the US.
Founded in 1999 in Berlin, Germany, JPK Instruments AG is a supplier of atomic force microscopes (AFM) and accessories for life science research. AFM measures the physical, electrical and magnetic forces on a sample surface with subnanometer resolution. In life science research, AFM is used to image the surfaces of living biological samples under physiological […]
For the fourth quarter of 2007, revenues for IBO’s Laboratory Sales Index grew 13.5% to $4,616 million and operating profits improved 23.0% to $833 million, leading operating margins 140 basis points higher to 18.0% of sales. For the year, the Laboratory Instrument Index reported similar revenue growth, climbing 13.5% to $17,030 million. Operating profits grew […]
According to Hong Yaxiong, deputy director of the department of policy for China’s State Environmental Protection Administration (SEPA), a new environmental ministry is likely to be created during the Eleventh National People’s Congress in March. The new ministry would assume SEPA’s duties and could also include the environmental duties of the Ministry of Land and […]
Nitrogen is an essential component of proteins, as well as many other biomolecules, making it an important analyte for applications involving the quantification of organic materials. Although there are many general spectroscopic methods that can be used to identify nitrogen, two main methods are used in instruments designed for total nitrogen (TN) determination: the Kjeldahl […]
It was a familiar story in 2007 for the world’s major pharmaceutical companies. Patent expirations, a decline in new product introductions, and regulatory and cost hurdles were the name of the game. Following in the steps of Merck and Pfizer (see IBO 4/15/06, 2/15/07), a number of the large drug companies announced major cost cutting […]
Following two weeks of speculation and a bidding process involving at least four companies, on February 4, GE Healthcare announced that it would acquire Whatman for $713 million in cash (see page 2, IBO 1/15/08). The 268-year-old company with forecasted 2007 revenues of £116 million ($232 million), Whatman is a name long associated with laboratory […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
